122 related articles for article (PubMed ID: 11009112)
1. Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep; 28(5):397-408. PubMed ID: 11009112
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo uric acid lowering by artificial cells containing microencapsulated genetically engineered E. coli DH5 cells.
Prakash S; Chang TM
Int J Artif Organs; 2000 Jul; 23(7):429-35. PubMed ID: 10941635
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on: 1. Column bioreactor and 2. Oral administration in uremic rats.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):201-18. PubMed ID: 8773740
[TBL] [Abstract][Full Text] [Related]
4. Artificial cell microcapsules containing genetically engineered E. coli DH5 cells for in-vitro lowering of plasma potassium, phosphate, magnesium, sodium, chloride, uric acid, cholesterol, and creatinine: a preliminary report.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1999; 27(5-6):475-81. PubMed ID: 10595451
[TBL] [Abstract][Full Text] [Related]
5. Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats.
Prakash S; Chang TM
Nat Med; 1996 Aug; 2(8):883-7. PubMed ID: 8705857
[TBL] [Abstract][Full Text] [Related]
6. Growth and survival of renal failure rats that received oral microencapsulated genetically engineered E. coli DH5 cells for urea removal.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1998 Jan; 26(1):35-51. PubMed ID: 9507755
[TBL] [Abstract][Full Text] [Related]
7. Free and microencapsulated Lactobacillus and effects of metabolic induction on urea removal.
Chow KM; Liu ZC; Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2003 Nov; 31(4):425-34. PubMed ID: 14672417
[TBL] [Abstract][Full Text] [Related]
8. Genetically engineered E. coli cells containing K. aerogenes gene, microencapsulated in artificial cells for urea and ammonia removal.
Prakash S; Chang TM
Biomater Artif Cells Immobilization Biotechnol; 1993; 21(5):629-36. PubMed ID: 8117852
[TBL] [Abstract][Full Text] [Related]
9. Growth kinetics of genetically engineered E. coli DH 5 cells in artificial cell APA membrane microcapsules: preliminary report.
Prakash S; Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 1999 May; 27(3):291-301. PubMed ID: 10226691
[TBL] [Abstract][Full Text] [Related]
10. Artificial cells with emphasis on cell encapsulation of genetically engineered cells.
Chang TM
Artif Organs; 1998 Nov; 22(11):958-65. PubMed ID: 9821530
[TBL] [Abstract][Full Text] [Related]
11. Procedures for microencapsulation of enzymes, cells and genetically engineered microorganisms.
Chang TM; Prakash S
Mol Biotechnol; 2001 Mar; 17(3):249-60. PubMed ID: 11434313
[TBL] [Abstract][Full Text] [Related]
12. [Study of alginate/chitosan microcapsules for immobilization of Escherichia coli DH5 alpha].
Fu YL; Xiong Y; Liu XD; Yu WT; Wang YL; Yu XJ; Ma XJ
Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):239-41. PubMed ID: 12148292
[TBL] [Abstract][Full Text] [Related]
13. Live E. coli cells to treat uremia.
Lange H
Nat Med; 1997 Jan; 3(1):2-3; author reply 3-4. PubMed ID: 8986725
[No Abstract] [Full Text] [Related]
14. Microencapsulated Saccharomyces cerevisiae column bioreactor for potential use in renal failure uremia.
Coussa RG; Shah S; Jain P; Martoni C; Bhathena J; Malhotra M; Prakash S
Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):103-12. PubMed ID: 22288841
[TBL] [Abstract][Full Text] [Related]
15. Live E. coli cells to treat uremia.
Wrong O
Nat Med; 1997 Jan; 3(1):3; author reply 3-4. PubMed ID: 8986726
[No Abstract] [Full Text] [Related]
16. Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal.
Prakash S; Chang TM
Biotechnol Bioeng; 1995 Jun; 46(6):621-6. PubMed ID: 18623357
[TBL] [Abstract][Full Text] [Related]
17. Artificial cells for bioencapsulation of cells and genetically engineered E. coli. For cell therapy, gene therapy, and removal of urea and ammonia.
Chang TM; Prakash S
Methods Mol Biol; 1997; 63():343-58. PubMed ID: 9113661
[No Abstract] [Full Text] [Related]
18. Establishment of colonic dialysis model in uremic rats by right nephrectomy and left partial nephrectomy.
Kajbafzadeh AM; Sabetkish N; Sabetkish S
J Pediatr Urol; 2018 Apr; 14(2):159.e1-159.e8. PubMed ID: 29456121
[TBL] [Abstract][Full Text] [Related]
19. Artificial cell biotechnology for medical applications.
Chang TM
Blood Purif; 2000; 18(2):91-6. PubMed ID: 10838466
[TBL] [Abstract][Full Text] [Related]
20. Sorbent membrane dialysis in uremia.
Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
